2026 Medical Fee Schedule Revision: What’s the Impact on Practicing Physicians? – Nikkei Medical

2026 Fiscal Year Medical Fee Schedule Revision and Medical M&A/Business Succession

The article reported by Nikkei Medical on the 2026 fiscal year medical fee schedule revision serves as a crucial reminder for healthcare institution executives about the importance of management decisions in response to changes in revenue structures. Specifically, the outlined revision directions, such as stricter facility standards and expanded utilization of regional healthcare cooperation promotion corporations, suggest the difficulty for individual medical institutions to adapt independently.

Such regulatory trends are extremely important in the context of medical M&A and business succession. Mergers and group formations aimed at achieving economies of scale, viewed as mid-to-long-term management strategies considering the revision cycle, can be effective options for maintaining facility standards, distributing the burden of capital investment, and securing specialized personnel. In particular, resource sharing and strengthened collaboration within a group are key to business continuity, especially to address facility standards that may become difficult to maintain independently.

For healthcare institution executives facing succession issues or considering future management strategies, it is essential to view the trends of this medical fee schedule revision not merely as a regulatory change, but as an opportunity to concretely consider business succession and M&A strategies. To ensure adaptability to regulatory changes and sustainable revenue generation, we recommend consulting with experts early on to explore the optimal options in light of your institution's specific management situation.